How to Prevent COVID-19 Vaccination From Interfering With Cancer Imaging
Education, communication, and coordination are key.
Education, communication, and coordination are key.
HLA-A*03 was associated with worse progression-free and overall survival.
Researchers identified misleading reporting in 75% of trials.
The risk of developing any cancer was significantly higher among patients with immune-mediated diseases.
Registry data show significant decreases in 14-day and 3-month case-fatality rates.
Recent studies showed associations between quality of life scores and survival in lung and prostate cancer as well as renal cell carcinoma.
Less than 10% of radiotherapy recommendations in 2020 NCCN guidelines were category 1 recommendations.
Respondents said some essential cancer drugs had substantial out-of-pocket costs, and some posed a high risk of catastrophic expenditure.
About half of patients with impaired seroconversion after the first dose of a COVID-19 vaccine still had low antibody levels after the second dose.
There was no increase in unresectable disease, new metastatic disease, or 30-day mortality associated with increasing delays.